Medpace Holdings [MEDP] vs Agilent Technologies [A] Detailed Stock Comparison

Medpace Holdings Inc.

NASDAQ
Loading...

Agilent Technologies Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medpace Holdings Inc. wins in 9 metrics, Agilent Technologies Inc. wins in 11 metrics, with 0 ties. Agilent Technologies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medpace Holdings Inc. Agilent Technologies Inc. Better
P/E Ratio (TTM) 26.90 25.67 Agilent Technologies Inc.
Price-to-Book Ratio 25.37 4.76 Agilent Technologies Inc.
Debt-to-Equity Ratio 20.43 51.39 Medpace Holdings Inc.
PEG Ratio 1.75 -7.19 Medpace Holdings Inc.
EV/EBITDA 18.94 17.32 Agilent Technologies Inc.
Profit Margin (TTM) 17.19% 18.26% Agilent Technologies Inc.
Operating Margin (TTM) 20.03% 22.86% Agilent Technologies Inc.
EBITDA Margin (TTM) 20.03% 22.86% Agilent Technologies Inc.
Return on Equity 77.25% 19.95% Medpace Holdings Inc.
Return on Assets (TTM) 17.47% 8.53% Medpace Holdings Inc.
Free Cash Flow (TTM) $681.87M $1.15B Agilent Technologies Inc.
Dividend Yield N/A 0.68% N/A
1-Year Return 56.69% 10.90% Medpace Holdings Inc.
Price-to-Sales Ratio (TTM) 4.38 4.65 Medpace Holdings Inc.
Enterprise Value $11.19B $34.13B Agilent Technologies Inc.
EV/Revenue Ratio 4.18 4.83 Medpace Holdings Inc.
Gross Profit Margin (TTM) 27.78% 52.61% Agilent Technologies Inc.
Revenue per Share (TTM) $94 $25 Medpace Holdings Inc.
Earnings per Share (Diluted) $15.26 $4.53 Medpace Holdings Inc.
Beta (Stock Volatility) 1.39 1.30 Agilent Technologies Inc.
Short % of Float 5.30% 1.83% Agilent Technologies Inc.

Medpace Holdings Inc. vs Agilent Technologies Inc. Stock Performance Analysis

Loading Price Chart...

MEDP
A

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings Inc.0.03%2.10%12.58%3.06%-16.39%-18.13%
Agilent Technologies Inc.-3.41%-2.11%3.78%7.87%-3.22%-4.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings Inc.56.69%110.68%163.23%1,566.69%1,566.69%1,566.69%
Agilent Technologies Inc.10.90%7.19%-10.46%186.24%282.67%444.17%

Performance & Financial Health Analysis: Medpace Holdings Inc. vs Agilent Technologies Inc.

MetricMEDPA
Market Information
Market Cap i$11.72B$32.65B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i574,9121,922,585
90 Day Avg. Volume i396,3541,892,452
Last Close$467.50$131.46
52 Week Range$294.07 - $628.92$108.35 - $160.27
% from 52W High-25.67%-17.98%
All-Time High$628.92 (Jan 16, 2026)$179.57 (Aug 30, 2021)
% from All-Time High-25.67%-26.79%
Growth Metrics
Quarterly Revenue Growth0.27%0.07%
Quarterly Earnings Growth0.08%-0.04%
Financial Health
Profit Margin (TTM) i0.17%0.18%
Operating Margin (TTM) i0.20%0.23%
Return on Equity (TTM) i0.77%0.20%
Debt to Equity (MRQ) i20.4351.39
Cash & Liquidity
Book Value per Share (MRQ)$16.18$24.44
Cash per Share (MRQ)$22.85$6.22
Operating Cash Flow (TTM) i$739.17M$1.40B
Levered Free Cash Flow (TTM) i$514.58M$855.88M
Dividends
Last 12-Month Dividend Yield iN/A0.68%
Last 12-Month Dividend iN/A$1.01

Valuation & Enterprise Metrics Analysis: Medpace Holdings Inc. vs Agilent Technologies Inc.

MetricMEDP (Apr 26, 2026)A (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i26.9025.67
Forward P/E i21.9717.67
PEG Ratio i1.75-7.19
Price to Sales (TTM) i4.384.65
Price to Book (MRQ) i25.374.76
Market Capitalization
Market Capitalization i$11.72B$32.65B
Enterprise Value i$11.19B$34.13B
Enterprise Value Metrics
Enterprise to Revenue i4.184.83
Enterprise to EBITDA i18.9417.32
Risk & Other Metrics
Beta i1.391.30
Book Value per Share (MRQ) i$16.18$24.44

Financial Statements Comparison: Medpace Holdings Inc. vs Agilent Technologies Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMEDP (2025)A (2025)
Revenue/Sales i2.53B6.95B
Cost of Goods Sold i1.77B3.31B
COGS % of Revenue i69.9%47.6%
Gross Profit i760.62M3.64B
Gross Margin i30.1%52.4%
Research & Development iN/A455.00M
Operating Income (EBIT) i534.94M1.48B
Operating Margin i21.1%21.3%
EBITDA i570.79M1.84B
EBITDA Margin i22.6%26.4%
Pre-Tax Income i542.38M1.44B
Pre-Tax Income % of Revenue i21.4%20.7%
Income Tax i91.25M132.00M
Income Tax % of Revenue i3.6%1.9%
Net Income (Profit) i451.12M1.30B
Profit Margin i17.8%18.8%

Balance Sheet & Liquidity Metrics

MetricMEDP (2025)A (2025)
Cash & Equivalents i497.05M1.79B
Total Current Assets i989.62M4.59B
Total Current Assets % of Revenue i39.1%66.1%
Total Current Liabilities i1.34B2.35B
Total Current Liabilities % of Revenue i53.1%33.8%
Long-Term Debt i113.64M3.05B
Long-Term Debt % of Revenue i4.5%43.9%
Total Shareholders Equity i459.07M6.74B
Retained Earnings i-459.98M1.39B
Retained Earnings % of Revenue i-18.2%20.0%
Property, Plant & Equipment i171.17M0

Cash Flow Statement Comparison

MetricMEDP (2025)A (2025)
Operating Cash Flow i643.24M1.51B
Operating Cash Flow % of Revenue i25.4%21.7%
Capital Expenditures i-31.36M-407.00M
Free Cash Flow i681.87M1.15B
FCF Margin i26.9%16.6%
Debt Repayment i0-3.00M
Common Stock Repurchase i-917.39M-425.00M

Short Interest & Institutional Ownership Analysis

MetricMEDPA
Shares Short i1.22M4.55M
Short Ratio i3.931.93
Short % of Float i5.30%1.83%
Shares Outstanding i28.56M282.70M
Float Shares i23.01M281.64M
% Held by Insiders i19.39%0.19%
% Held by Institutions i86.88%93.87%
% Held by Public i-6.27%5.94%

Dividend Analysis & Yield Comparison: Medpace Holdings Inc. vs Agilent Technologies Inc.

MetricMEDPA
Last 12-Month Dividend iN/A$1.01
Last 12-Month Dividend Yield iN/A0.68%
3-Year Avg Annual Dividend iN/A$0.97
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$2.91
Ex-Dividend DateN/AJan 06, 2026